Cumberland Pharma Sets IPO Terms

Cumberland Pharmaceuticals Inc., a Nashville, Tenn.-based specialty drug company that acquires and commercializes niche products, has set its IPO terms to 6.25 million common shares being offered at between $14 and $16 per share. It would have an initial market cap of around $285 million, if it were to price at the high end of its range. The company plans to trade on the Nasdaq under ticker symbol CPIX, with UBS serving as lead underwriters. Shareholders include Scout Healthcare Fund. www.cumberlandpharma.com